News | Radiology Business | February 28, 2022

Boston Imaging reflects the company’s commitment to delivering best-in-class Samsung imaging devices to customers nationwide

NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, announced today that the company’s Digital Radiography and Ultrasound (DR & US) business will operate under a new brand called Boston Imaging.

February 28, 2022 — NeuroLogica Corp., the U.S. healthcare subsidiary of Samsung, announced today that the company’s Digital Radiography and Ultrasound (DR & US) business will operate under a new brand called Boston Imaging.

“This is a momentous day for the company, as it will allow us even greater focus on our core expertise, providing the U.S. market with innovative, best-in-class Digital Radiography and Ultrasound imaging devices with Samsung healthcare technology at the core,” said David Legg, Vice President, Ultrasound and Digital Radiography, Boston Imaging. “As we continue gaining market leadership, this change will also allow Boston Imaging to have a more dedicated focus for growing the business.”

“The Samsung name is synonymous with industry-leading imaging technology,” said Legg. “In the healthcare imaging market, Samsung is the only true technology company that is now in healthcare imaging, while competitors come from industrial roots that have pursued healthcare as an add-on business. This company specializes in delivering exquisite imaging results.” Our new brand, Boston Imaging, reinforces the strength of our legacy and signals the potential of our future.

Our past advancements and achievements within the two modalities include the current introduction of innovative products such as the V8 Ultrasound system and artificial intelligence solutions, like Auto Lung Nodule Detection (ALND) tool, in Digital Radiography.

Boston Imaging’s team mission is improving patient care by developing outstanding, customer-centric imaging solutions quickly and with passion. We remain committed to our vision of making the world a healthier place by empowering clinicians to diagnose their patients more confidently, quickly and cost-effectively.

We will continue to maintain our normal business operations and operating structure. The legal entity and name of the company remains NeuroLogica Corp. We will be Doing Business As (DBA), Boston Imaging. The mobile computed tomography (CT) business will continue to operate under the existing company name, NeuroLogica.

For more information: www.bostonimaging.com


Related Content

News | Contrast Media

April 24, 2024 — The International Contrast Ultrasound Society (ICUS) and Northwest Imaging Forums (NWIF) announced an ...

Time April 24, 2024
arrow
News | Artificial Intelligence

April 19, 2024 — Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology ...

Time April 22, 2024
arrow
News | Mammography

April 16, 2024 — The Radiological Society of North America (RSNA) and GE HealthCare announced their collaboration to ...

Time April 16, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

April 8, 2024 — Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive technique for neuroregulation ...

Time April 08, 2024
arrow
News | Radiology Business

April 4, 2024 — FUJIFILM Healthcare Americas Corporation, a leading provider of diagnostic and enterprise imaging ...

Time April 04, 2024
arrow
News | Radiation Oncology

April 2, 2024 — In a 10-center study, microwave ablation offered progression free survival rates and fewer complications ...

Time April 02, 2024
arrow
News | X-Ray

April 1, 2024 — MinXray, a leading manufacturer of imaging systems for medical and veterinary use, recently sent its ...

Time April 01, 2024
arrow
News | PACS

April 1, 2024 — SynthesisHealth LLC has completed the implementation of components that enable remote clinical ...

Time April 01, 2024
arrow
News | Electronic Medical Records (EMR)

March 28, 2024 — Immediately releasing radiology reports under the 21st Century Cures Act (Cures Act) empowers patients ...

Time March 28, 2024
arrow
News | Radiation Therapy

March 28, 2024 — RefleXion Medical, Inc., a therapeutic oncology company, and Limbus AI, Inc., a provider of software ...

Time March 28, 2024
arrow
Subscribe Now